Get a job referral to Editas Medicine
Massachusetts, United States
201-500 Employees
Healthcare
•Tech
Description
Editas Medicine (NASDAQ: EDIT) is a leading biotechnology company that specializes in genome editing. Founded with a vision to harness the power of CRISPR technology, Editas Medicine is at the forefront of developing innovative therapies to address genetic diseases. Their groundbreaking research and development efforts have the potential to revolutionize the field of medicine by offering targeted treatments for a wide range of genetic disorders. Editas Medicine is dedicated to advancing precision medicine and improving patient outcomes through cutting-edge genome editing technologies.
Editas Medicine
Senior Director, Process DevelopmentEditas Medicine
Scientist II, Molecular Biology & Gene EditingEditas Medicine
Associate Corporate CounselEditas Medicine
Scientist I, In Vivo DiscoveryEditas Medicine
Gene Editing ExpertEditas Medicine
Associate CorporateEditas Medicine
Legal Counsel in Gene EditingEditas Medicine
Associate Corporate CounselEditas Medicine
Research Associate, Molecular BioanalyticsEditas Medicine
Senior Formulation ScientistFinancials
Type
public
Annual Revenue
--
Market Cap
$115.3M+
Referrals
Editas Medicine accepts referrals. The typical bonus is $--. Read more about Editas Medicine referral bonuses.
Subscribe to Refer Me premium to get referred to your dream role at Editas Medicine!
